UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Valuation of Medical Innovation Handling with Uncertainty and Risk

Journal of market access & health policy, 2024-08, Vol.12 (3), p.199-208

2024

Volltextzugriff (PDF)

Efficiency ratio and rocketing drug prices: old concerns and new possibilities

The European journal of health economics, 2020-12, Vol.21 (9), p.1273-1277

2020

Volltextzugriff (PDF)

Estimating the budget impact of innovative pharmacological treatments for patients with type 2 diabetes mellitus in Italy: the case of liraglutide (GLP-1)

Epidemiology, biostatistics, and public health, 2022-05, Vol.12 (2)

2022

Volltextzugriff (PDF)

An integrated valuation model for payer and investor

Journal of market access & health policy, 2022, Vol.10 (1), p.2080631-2080631

2022

Volltextzugriff (PDF)

Pricing of orphan drugs in oncology and rare diseases

Journal of market access & health policy, 2020, Vol.8 (1), p.1838191-1838191

2020

Volltextzugriff (PDF)

Atherogenic Dyslipidemias: Unmet Needs and the Therapeutic Potential of Emerging and Novel Approaches and Drugs

Pharmaceuticals (Basel, Switzerland), 2023-01, Vol.16 (2), p.176

2023

Volltextzugriff (PDF)

Cost-effectiveness of Pazopanib Versus Sunitinib as First-line Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma from an Italian National Health Service Perspective

Clinical therapeutics, 2017-03, Vol.39 (3), p.567-580.e2

2017

Volltextzugriff (PDF)

Cost-effectiveness analysis of different seasonal influenza vaccines in the elderly Italian population

Human vaccines & immunotherapeutics, 2018-06, Vol.14 (6), p.1331-1341

2018

Volltextzugriff (PDF)

I costi dei pazienti con patologie infiammatorie dell’intestino (Malattia di Crohn e colite ulcerosa). Studio real world in Italia

Global & regional health technology assessment (Online), 2018-01, Vol.2018, p.228424031879328

2018

Volltextzugriff (PDF)

Extracorporeal Photopheresis for Second-Line Treatment of Chronic Graft-versus-Host Diseases: Results from a Health Technology Assessment in Italy

Value in health, 2015-06, Vol.18 (4), p.457-466

2015

Volltextzugriff (PDF)

Cost of breast cancer based on real-world data: a cancer registry study in Italy

BMC health services research, 2017-01, Vol.17 (1), p.84-84, Article 84

2017

Volltextzugriff (PDF)

Budget impact analysis for avatrombopag in the treatment of chronic primary immune thrombocytopenia in adult patients refractory to other treatments

Journal of market access & health policy, 2023, Vol.11 (1), p.2230663-2230663

2023

Volltextzugriff (PDF)

An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators

Journal of market access & health policy, 2024-03, Vol.12 (1), p.21-34

2024

Volltextzugriff (PDF)

The role of stakeholder involvement in the evolving EU HTA process: Insights generated through the European Access Academy's multi-stakeholder pre-convention questionnaire

Journal of market access & health policy, 2023, Vol.11 (1), p.2217543-2217543

2023

Volltextzugriff (PDF)

Feasibility and attractiveness of indication value-based pricing in key EU countries

Journal of market access & health policy, 2016, Vol.4 (1), p.30970-7

2016

Volltextzugriff (PDF)

Approaches to manage 'affordability' of high budget impact medicines in key EU countries

Journal of market access & health policy, 2018, Vol.6 (1), p.1478539-8

2018

Volltextzugriff (PDF)

Economic evaluation of tocilizumab combination in the treatment of moderate-to-severe rheumatoid arthritis in Italy

Journal of medical economics, 2012, Vol.15 (3), p.576-585

2012

Volltextzugriff (PDF)

Is vaccination good value for money? A review of cost-utility analyses of vaccination strategies in eight European countries

Epidemiology, biostatistics, and public health, 2022-04, Vol.13 (4)

2022

Volltextzugriff (PDF)

Economic value of influenza vaccination

Human vaccines & immunotherapeutics, 2012-01, Vol.8 (1), p.119-129

2012

Volltextzugriff (PDF)

The impact of conventional cost-effectiveness analysis on pricing dynamics in the market of new medicines: a proposed countervailing approach

Expert review of pharmacoeconomics & outcomes research, 2023-04, Vol.23 (4), p.431-438

2023

Volltextzugriff (PDF)

I costi dei pazienti con patologie infiammatorie dell’intestino (Malattia di Crohn e colite ulcerosa). Studio real world in Italia

Global & regional health technology assessment (Online), 2018-08, Vol.5 (1)

2018

Volltextzugriff (PDF)

I costi dei pazienti con patologie infiammatorie dell’intestino (Malattia di Crohn e colite ulcerosa). Studio in Italia

Global & regional health technology assessment (Online), 2018-08, Vol.2018

2018

Volltextzugriff (PDF)

Screening for sickle cell disease: focus on newborn investigations

Clinical chemistry and laboratory medicine, 2024-08, Vol.62 (9), p.1804-1813

2024

Volltextzugriff (PDF)

Guidance for future HTA applications to vaccines: The HPV lesson

Human vaccines, 2011-09, Vol.7 (9), p.900-904

2011

Volltextzugriff (PDF)

Guidelines for Economic Evaluations in Italy: Recommendations from the Italian Group of Pharmacoeconomic Studies

Drug information journal, 2001-01, Vol.35 (1), p.189-201

2001

Volltextzugriff (PDF)

1 – 25 von 155

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(125)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(153)
Italienisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Valuation of Medical Innovation Handling with Uncertainty and Risk

Efficiency ratio and rocketing drug prices: old concerns and new possibilities

Estimating the budget impact of innovative pharmacological treatments for patients with type 2 diabetes mellitus in Italy: the case of liraglutide (GLP-1)

An integrated valuation model for payer and investor

Pricing of orphan drugs in oncology and rare diseases

Atherogenic Dyslipidemias: Unmet Needs and the Therapeutic Potential of Emerging and Novel Approaches and Drugs

Cost-effectiveness of Pazopanib Versus Sunitinib as First-line Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma from an Italian National Health Service Perspective

Cost-effectiveness analysis of different seasonal influenza vaccines in the elderly Italian population

I costi dei pazienti con patologie infiammatorie dell’intestino (Malattia di Crohn e colite ulcerosa). Studio real world in Italia

Extracorporeal Photopheresis for Second-Line Treatment of Chronic Graft-versus-Host Diseases: Results from a Health Technology Assessment in Italy

Cost of breast cancer based on real-world data: a cancer registry study in Italy

Budget impact analysis for avatrombopag in the treatment of chronic primary immune thrombocytopenia in adult patients refractory to other treatments

An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators

The role of stakeholder involvement in the evolving EU HTA process: Insights generated through the European Access Academy's multi-stakeholder pre-convention questionnaire

Feasibility and attractiveness of indication value-based pricing in key EU countries

Approaches to manage 'affordability' of high budget impact medicines in key EU countries

Economic evaluation of tocilizumab combination in the treatment of moderate-to-severe rheumatoid arthritis in Italy

Is vaccination good value for money? A review of cost-utility analyses of vaccination strategies in eight European countries

Economic value of influenza vaccination

The impact of conventional cost-effectiveness analysis on pricing dynamics in the market of new medicines: a proposed countervailing approach

I costi dei pazienti con patologie infiammatorie dell’intestino (Malattia di Crohn e colite ulcerosa). Studio real world in Italia

I costi dei pazienti con patologie infiammatorie dell’intestino (Malattia di Crohn e colite ulcerosa). Studio in Italia

Screening for sickle cell disease: focus on newborn investigations

Guidance for future HTA applications to vaccines: The HPV lesson

Guidelines for Economic Evaluations in Italy: Recommendations from the Italian Group of Pharmacoeconomic Studies

Suchergebnisse filtern